US20140058199A1 - Method for determining measured data from the stomach of a patient - Google Patents

Method for determining measured data from the stomach of a patient Download PDF

Info

Publication number
US20140058199A1
US20140058199A1 US14/073,170 US201314073170A US2014058199A1 US 20140058199 A1 US20140058199 A1 US 20140058199A1 US 201314073170 A US201314073170 A US 201314073170A US 2014058199 A1 US2014058199 A1 US 2014058199A1
Authority
US
United States
Prior art keywords
stomach
patient
drink solution
endoscope
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/073,170
Inventor
Norbert Glasel
Rainer Kuth
Bernhard Roas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens AG
Original Assignee
Siemens AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens AG filed Critical Siemens AG
Priority to US14/073,170 priority Critical patent/US20140058199A1/en
Assigned to SIEMENS AKTIENGESELLSCHAFT reassignment SIEMENS AKTIENGESELLSCHAFT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KUTH, RAINER, ROAS, BERNHARD, GLAESEL, NORBERT
Publication of US20140058199A1 publication Critical patent/US20140058199A1/en
Priority to US15/240,340 priority patent/US10231606B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041Capsule endoscopes for imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147Holding or positioning arrangements
    • A61B1/00158Holding or positioning arrangements using magnetic field
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
    • A61B1/2736Gastroscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Definitions

  • the invention concerns a method to determine measurement data from the stomach of a patient, of the type wherein an endoscope is used to acquire measurement data in the stomach of a patient and an aqueous drink solution is present in the stomach of the patient.
  • the invention moreover concerns a drink solution for the implementation of such a method.
  • an endoscope means both a generally known, classical endoscope which is brought into the stomach of a patient with the use of a tube directed through the mouth or nose of the patient, and a capsule endoscope (known for example from DE 101 42 253 C1) that the patient can independently swallow.
  • a drink solution is a liquid provided for use in the field of medicine that is selectively brought into the stomach of a patient with a stomach probe or is administered to the patient for independent ingestion.
  • different variables, measurement values or samples are taken inside the stomach and provided to a physician or assistant for evaluation.
  • content substances or concentrations of the stomach contents are measured, the chemical composition of the gastric juices are determined or image data of the stomach mucosa are collected.
  • a tube In classical endoscopy, a tube is directed through the mouth or nose of the patient into his stomach. Since the stomach is a hollow muscle, this is normally expanded by blowing in a gas (for example air or CO 2 ), in particular for the implementation of visual examinations. As a result of this expansion, regions of the stomach that are otherwise covered by the mucosa folds are also accessible.
  • a gas for example air or CO 2
  • a variant that is more comfortable and gentle for the patient relative to classical gastroscopy uses a capsule endoscope that can be swallowed.
  • the capsule endoscope/the endoscopy capsule is connected (for example via a radio connection) with a transmission station placed in proximity to the patient.
  • the capsule endoscope can be magnetically navigable.
  • This type of capsule endoscopy is also designated as MGCE (Engl.: magnetically guided capsule endoscopy).
  • MGCE Magnetically guided capsule endoscopy
  • a capsule endoscope that is suitable for this method arises from DE 101 42 253 C1, which was already mentioned.
  • the stomach is expanded not with a gas but rather with the aid of a liquid.
  • multiple measurement errors have been observed in the acquisition of measurement data.
  • An object of the invention is to provide a method to determine measurement data from inside the stomach which is improved with regard to its precision.
  • the invention also encompasses a drink solution for application in such a method that allows an improved accuracy in the measurement value acquisition.
  • an endoscope to acquire the measurement data is present in the stomach of the patient to obtain measurement data from said stomach.
  • an aqueous drink solution that is previously degassed is present in the stomach of the patient.
  • a degassed drink solution is a drink solution that is free of dissolved gases at least insofar as that gas bubble formation is nearly precluded when this is brought into the stomach of the patient.
  • the conditions prevailing in the stomach of a patient are to be taken into account in this context.
  • the drink solution is thus degassed at least insofar as that this no longer outgasses given the conditions prevailing in the stomach of the patient, for example with regard to temperature, pH value etc.
  • a complete degassing of the drink solution is normally not necessary in this context.
  • the method according to the invention is based on the following insight.
  • reactions can occur between the liquid used for the expansion and the stomach contents, in particular the gastric juices.
  • the formation of gas bubbles has been observed multiple times in the chemical and/or physical interaction between the liquid and the stomach contents.
  • a gas bubble development inside the stomach has been connected with the occurring measurement errors of the probes present in the endoscope.
  • a bubble development is particularly critical for the acquisition of optical image data of the stomach mucosa. Finely distributed bubbles dissolved in the liquid used to expand the stomach reduce its optical quality and lead to a high proportion of scattered light in the image data. Moreover, bubbles adhering to the outside of the capsule can cause image errors since the optics used to acquire the image data are entirely or partially covered.
  • the gas bubble formation inside the stomach is particularly problematic for a magnetically navigable capsule endoscope.
  • an adhesion of gas bubbles to the surface of the capsule leads to unwanted local buoyancy forces that can cause the capsule to tumble but at least significantly hinder its navigability.
  • the bubble formation occurring in the stomach could be identified as a primary cause for arising measurement errors.
  • the drink solution is degassed according to the invention. This measure is motivated by the following considerations.
  • the drink solution that is transported into the stomach to expand it is in contact with both the stomach contents and the stomach mucosa.
  • various chemical reactions can occur between this and the stomach contents or, respectively, the gastric juices produced by the stomach mucosa.
  • One example is the variation of the pH value of the drink solution due to the (typically acidic) gastric juices. If the pH value drops, the solubility of CO 2 in water decreases, such that this outgasses. This and other reactions have been connected with a gas formation inside the stomach. An additional effect that leads to the gas bubble formation inside the stomach is the warming of the drink solution.
  • the solubility of the gases present in the drink solution decreases, whereby these escape.
  • the drink solution is degassed before this is brought into the stomach of the patient.
  • the drink solution is thus freed of dissolved gases at least insofar as that a gas bubble development is nearly precluded if said solution is brought into the stomach of the patient.
  • Particular attention is thereby granted to the gases CO 2 , N 2 and O 2 .
  • These gases represent the primary components of ambient air and are correspondingly dissolved in drinking water, for example.
  • the drink solution is advantageously predominantly freed of these gases.
  • the gas bubble development that is suppressed in this manner has an advantageous effect on the precision of the measurement values detected with the endoscope.
  • conventional measurement methods that use a drink solution that has not been degassed, it has been repeatedly observed that gas bubbles adhere to the sensors of the endoscope and in this way cause severe measurement errors.
  • severe distortions occur in conventional measurement methods.
  • the drink solution can become turbid due to dissolved gas bubbles, such that the image data appear indistinct or exhibit a high proportion of scattered light.
  • the aqueous drink solution according to the invention that is for use in a measurement method in which this is present in the stomach of a patient in additional to an endoscope for acquisition of measurement data is characterized in that this solution is degassed.
  • the drink solution is freed of dissolved gases at least insofar as that a gas bubble development is nearly precluded when this is brought into the stomach of the patient.
  • a degassed drink solution is administered to the patient.
  • the drink solution can be independently taken by the patient, but it can also be brought into his stomach with a probe, for example.
  • the fluid level in the stomach of the patient can be monitored with the aid of ultrasound.
  • drink solution can moreover be additionally drunk by the patient or be brought into his stomach in another manner.
  • this is subjected to a vacuum degassing before it is brought into the stomach of the patient.
  • the vacuum degasing is easily controllable via technical measures and is inexpensive; it can possibly be supported via additional measures for degassing.
  • the drink solution can additionally be heated to expel the dissolved gases.
  • Osmotic reactions at the stomach wall represent an additional source for the gas bubble formation inside the stomach. According to a further exemplary embodiment, these reactions can be suppressed via an isotonic preparation of the drink solution.
  • the drink solution that is pre-treated in such a manner has the same osmotic pressure as human blood. Osmotic reactions at the stomach mucosa can thus be avoided.
  • the gas bubble development inside the stomach can be prevented or at least can be severely reduced via the reduction or significant avoidance of such osmotic reactions at the stomach wall.
  • the drink solution is preferably prepared isotonically via the addition of sodium chloride, i.e. is compounded with 0.9% by weight of cooking salt.
  • an additional problem in the acquisition of measurement data inside the human or animal stomach is foaming caused by the peristalsis of the stomach. Foam that is present in the stomach in particular hinders the acquisition of optical image data. This applies for both a conventional endoscope and for an endoscopy capsule. In the following reference is made to a capsule endoscope as an example.
  • the endoscope possesses one or more cameras to acquire image data.
  • the endoscopy capsule In its working position the endoscopy capsule is located at or in proximity to the surface of the drink solution located in the stomach.
  • the endoscopy capsule advantageously possesses multiple cameras, of which a first camera acquires optical data of the stomach mucosa through the drink solution from below the liquid level, for example.
  • An additional camera can be arranged above the liquid level to acquire image data. In particular, the latter is significantly affected by foam formation inside the stomach.
  • the drink solution is compounded with a defoaming agent, advantageously with a silicone oil.
  • a defoaming agent advantageously with a silicone oil.
  • silicone oil is particularly advantageous since this is physiologically harmless; silicone oil is inert inside the body, as is known from silicone implants.
  • the addition of silicon oil produces a reduction of the surface tension of the drink solution provided in the stomach. This leads to a reduction of the foam formation.
  • the endoscope can also detect additional variables, for example concentrations of specific content substances present in the stomach.
  • concentrations of specific content substances present in the stomach is the measurement of the ammonia content of the stomach contents.
  • Ammonia exists as both NH 3 and NH 4 + in an aqueous environment.
  • the equilibrium between NH 3 and NH 4 + shifts depending on the pH value prevailing in the stomach.
  • the pH value in the stomach of the patient has approximately the same value in every measurement. This in particular applies for a time-dependent measurement of the NH 3 concentration. In such a measurement the variation of the NH 3 concentration in a certain time period is observed.
  • the drink solution is compounded with a pH buffer.
  • a citric acid-phosphate buffer is advantageously used.
  • Such a buffer also called a Mcllvaine buffer
  • a mixture of 0.1 molar citric acid (solution A) and 0.2 molar NaHPO 4 .4H 2 O solution (solution B) of buffer composition X ml A+(100 ⁇ X) ml B is designated as a Mcllvaine buffer.
  • a drink solution provided into the stomach remains there only for a relatively short period of time.
  • the temperature of the drink solution is calibrated essentially to the temperature of the stomach to extend the residence duration.
  • a drink solution that is preheated to approximately body temperature has multiple advantages. On the one hand, temperature-dependent density changes within the drink solution do not occur. Such density changes lead to variations in the index of refraction of the drink solution and thus lead to streak formation in the image data. Moreover, a warm drink solution will drain more slowly from the pylorus into the duodenum than a cold drink solution. The residence duration of the preheated drink solution in the stomach is thus improved.
  • a technical problem which occurs in the use of a drink solution that has not been degassed is that bubbles accumulate on the outside of the endoscopy capsule.
  • the capsule can start to tumble; in this case a targeted measurement value acquisition is impossible.
  • the use of a degassed drink solution prevents the situation that bubbles can accumulate at the surface of the capsule endoscope.
  • the capsule endoscope can be navigated without problems.
  • the navigability/mobility of the endoscope capsule inside the stomach can be additionally improved in that a silicone oil is admixed with the drink solution.
  • this has the effect of a lubricant.
  • the friction forces between the capsule endoscope and the drink fluid and between the capsule endoscope and the stomach wall are reduced; the navigability of the capsule is improved.
  • the drink solution can be provided with the admixtures and be degassed insofar as this is necessary.
  • a prepared drink solution must merely be correspondingly tempered before it is brought into the stomach of the patient.
  • Such a prepared drink solution allows a high workflow in the measurement value acquisition.

Abstract

In a method to obtain measurement data from the stomach of a patient using an endoscope, a degassed aqueous drink solution is administered to the stomach of the patient and the measurement data are acquired with the degassed aqueous drink solution present in the stomach.

Description

    RELATED APPLICATION
  • The present application is a divisional application of application Ser. No. 13/056,394, filed on Jan. 28, 2011.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The invention concerns a method to determine measurement data from the stomach of a patient, of the type wherein an endoscope is used to acquire measurement data in the stomach of a patient and an aqueous drink solution is present in the stomach of the patient. The invention moreover concerns a drink solution for the implementation of such a method.
  • 2. Description of the Prior Art
  • As used herein, an endoscope means both a generally known, classical endoscope which is brought into the stomach of a patient with the use of a tube directed through the mouth or nose of the patient, and a capsule endoscope (known for example from DE 101 42 253 C1) that the patient can independently swallow. A drink solution is a liquid provided for use in the field of medicine that is selectively brought into the stomach of a patient with a stomach probe or is administered to the patient for independent ingestion.
  • An endoscopically implemented examination of the human or animal stomach—a gastroscopy—is part of a routine examination in everyday medical practice. Within the framework of the gastroscopy, different variables, measurement values or samples are taken inside the stomach and provided to a physician or assistant for evaluation. For example, content substances or concentrations of the stomach contents are measured, the chemical composition of the gastric juices are determined or image data of the stomach mucosa are collected.
  • In classical endoscopy, a tube is directed through the mouth or nose of the patient into his stomach. Since the stomach is a hollow muscle, this is normally expanded by blowing in a gas (for example air or CO2), in particular for the implementation of visual examinations. As a result of this expansion, regions of the stomach that are otherwise covered by the mucosa folds are also accessible.
  • A variant that is more comfortable and gentle for the patient relative to classical gastroscopy uses a capsule endoscope that can be swallowed. To transfer measurement data from inside the stomach, the capsule endoscope/the endoscopy capsule is connected (for example via a radio connection) with a transmission station placed in proximity to the patient. For targeted acquisition of measurement and/or image data from specific regions of the stomach, the capsule endoscope can be magnetically navigable. This type of capsule endoscopy is also designated as MGCE (Engl.: magnetically guided capsule endoscopy). For example, a capsule endoscope that is suitable for this method arises from DE 101 42 253 C1, which was already mentioned. In contrast to conventional gastroscopy, in capsule endoscopy the stomach is expanded not with a gas but rather with the aid of a liquid. However, multiple measurement errors have been observed in the acquisition of measurement data.
  • SUMMARY OF THE INVENTION
  • An object of the invention is to provide a method to determine measurement data from inside the stomach which is improved with regard to its precision. The invention also encompasses a drink solution for application in such a method that allows an improved accuracy in the measurement value acquisition.
  • In the method according to the invention an endoscope to acquire the measurement data is present in the stomach of the patient to obtain measurement data from said stomach.
  • During the acquisition of the measurement data, an aqueous drink solution that is previously degassed is present in the stomach of the patient.
  • As used herein, a degassed drink solution is a drink solution that is free of dissolved gases at least insofar as that gas bubble formation is nearly precluded when this is brought into the stomach of the patient. The conditions prevailing in the stomach of a patient are to be taken into account in this context. The drink solution is thus degassed at least insofar as that this no longer outgasses given the conditions prevailing in the stomach of the patient, for example with regard to temperature, pH value etc. A complete degassing of the drink solution is normally not necessary in this context.
  • The method according to the invention is based on the following insight.
  • The expansion of the stomach with the use of a liquid that is particularly advantageous for capsule endoscopy entails different technical problems. However, the following statements apply for both classical endoscopy and capsule endoscopy.
  • For example, reactions can occur between the liquid used for the expansion and the stomach contents, in particular the gastric juices. The formation of gas bubbles has been observed multiple times in the chemical and/or physical interaction between the liquid and the stomach contents. A gas bubble development inside the stomach has been connected with the occurring measurement errors of the probes present in the endoscope.
  • A bubble development is particularly critical for the acquisition of optical image data of the stomach mucosa. Finely distributed bubbles dissolved in the liquid used to expand the stomach reduce its optical quality and lead to a high proportion of scattered light in the image data. Moreover, bubbles adhering to the outside of the capsule can cause image errors since the optics used to acquire the image data are entirely or partially covered.
  • The gas bubble formation inside the stomach is particularly problematic for a magnetically navigable capsule endoscope. For example, an adhesion of gas bubbles to the surface of the capsule leads to unwanted local buoyancy forces that can cause the capsule to tumble but at least significantly hinder its navigability.
  • In summary, the bubble formation occurring in the stomach could be identified as a primary cause for arising measurement errors. To avoid the gas formation, the drink solution is degassed according to the invention. This measure is motivated by the following considerations.
  • The drink solution that is transported into the stomach to expand it is in contact with both the stomach contents and the stomach mucosa. After the drink solution has been introduced into the stomach of the patient, various chemical reactions can occur between this and the stomach contents or, respectively, the gastric juices produced by the stomach mucosa. One example is the variation of the pH value of the drink solution due to the (typically acidic) gastric juices. If the pH value drops, the solubility of CO2 in water decreases, such that this outgasses. This and other reactions have been connected with a gas formation inside the stomach. An additional effect that leads to the gas bubble formation inside the stomach is the warming of the drink solution. In that the temperature of the drink solution increases—for example from room temperature or below this to the typical temperature of the stomach—the solubility of the gases present in the drink solution decreases, whereby these escape. In order to suppress the gas bubble formation that has been repeatedly observed, the drink solution is degassed before this is brought into the stomach of the patient. The drink solution is thus freed of dissolved gases at least insofar as that a gas bubble development is nearly precluded if said solution is brought into the stomach of the patient. Particular attention is thereby granted to the gases CO2, N2 and O2. These gases represent the primary components of ambient air and are correspondingly dissolved in drinking water, for example. The drink solution is advantageously predominantly freed of these gases.
  • The gas bubble development that is suppressed in this manner has an advantageous effect on the precision of the measurement values detected with the endoscope. In conventional measurement methods that use a drink solution that has not been degassed, it has been repeatedly observed that gas bubbles adhere to the sensors of the endoscope and in this way cause severe measurement errors. In particular in the acquisition of optical image data, severe distortions occur in conventional measurement methods. For example, the drink solution can become turbid due to dissolved gas bubbles, such that the image data appear indistinct or exhibit a high proportion of scattered light.
  • Both the determination of image data from inside the stomach of the patient and the determination of additional measurement data becomes significantly more reliable due to the degassing of the drink solution.
  • The aqueous drink solution according to the invention that is for use in a measurement method in which this is present in the stomach of a patient in additional to an endoscope for acquisition of measurement data is characterized in that this solution is degassed. As has already been mentioned above, the drink solution is freed of dissolved gases at least insofar as that a gas bubble development is nearly precluded when this is brought into the stomach of the patient.
  • Significant advantages of the drink solution according to the invention have already been cited in connection with the method according to the invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • In the following the invention is explained further using various exemplary embodiments.
  • To prepare the measurement a degassed drink solution is administered to the patient. The drink solution can be independently taken by the patient, but it can also be brought into his stomach with a probe, for example. The fluid level in the stomach of the patient can be monitored with the aid of ultrasound. In order to compensate for an outflow of the drink solution from the stomach, during the implementation of the measurements drink solution can moreover be additionally drunk by the patient or be brought into his stomach in another manner.
  • Within the scope of the preparation of the drink solution, according to a first exemplary embodiment this is subjected to a vacuum degassing before it is brought into the stomach of the patient. The vacuum degasing is easily controllable via technical measures and is inexpensive; it can possibly be supported via additional measures for degassing. For example, the drink solution can additionally be heated to expel the dissolved gases.
  • Osmotic reactions at the stomach wall represent an additional source for the gas bubble formation inside the stomach. According to a further exemplary embodiment, these reactions can be suppressed via an isotonic preparation of the drink solution. The drink solution that is pre-treated in such a manner has the same osmotic pressure as human blood. Osmotic reactions at the stomach mucosa can thus be avoided. The gas bubble development inside the stomach can be prevented or at least can be severely reduced via the reduction or significant avoidance of such osmotic reactions at the stomach wall. The drink solution is preferably prepared isotonically via the addition of sodium chloride, i.e. is compounded with 0.9% by weight of cooking salt.
  • Among other things, an additional problem in the acquisition of measurement data inside the human or animal stomach is foaming caused by the peristalsis of the stomach. Foam that is present in the stomach in particular hinders the acquisition of optical image data. This applies for both a conventional endoscope and for an endoscopy capsule. In the following reference is made to a capsule endoscope as an example.
  • The endoscope possesses one or more cameras to acquire image data. In its working position the endoscopy capsule is located at or in proximity to the surface of the drink solution located in the stomach. The endoscopy capsule advantageously possesses multiple cameras, of which a first camera acquires optical data of the stomach mucosa through the drink solution from below the liquid level, for example. An additional camera can be arranged above the liquid level to acquire image data. In particular, the latter is significantly affected by foam formation inside the stomach.
  • Foam present in the stomach hinders the acquisition of optical image data; however, other sensors that are possibly present at the endoscope can be disrupted by foam present in the stomach. To improve the working conditions of the endoscope inside the stomach, the drink solution is compounded with a defoaming agent, advantageously with a silicone oil. The use of silicone oil is particularly advantageous since this is physiologically harmless; silicone oil is inert inside the body, as is known from silicone implants. The addition of silicon oil produces a reduction of the surface tension of the drink solution provided in the stomach. This leads to a reduction of the foam formation.
  • As already mentioned, in addition to optical image data the endoscope can also detect additional variables, for example concentrations of specific content substances present in the stomach. One example is the measurement of the ammonia content of the stomach contents. Ammonia exists as both NH3 and NH4 + in an aqueous environment. The equilibrium between NH3 and NH4 + shifts depending on the pH value prevailing in the stomach. To determine a significant measurement value of the NH3 concentration it is decisive that the pH value in the stomach of the patient has approximately the same value in every measurement. This in particular applies for a time-dependent measurement of the NH3 concentration. In such a measurement the variation of the NH3 concentration in a certain time period is observed. Such a measurement could be disrupted by the continuously occurring production of gastric juices, for example. For this reason, according to a further exemplary embodiment the drink solution is compounded with a pH buffer. A citric acid-phosphate buffer is advantageously used. Such a buffer (also called a Mcllvaine buffer) can be adjusted in a pH range between 2.2 and 8. Its buffer range thus lies in a range of the acid environment of the stomach. A mixture of 0.1 molar citric acid (solution A) and 0.2 molar NaHPO4.4H2O solution (solution B) of buffer composition X ml A+(100−X) ml B is designated as a Mcllvaine buffer.
  • By adding a pH buffer, constant conditions can be set in the stomach of the patient. This is also advantageous for the acquisition of optical image data since variations in the index of refraction of the drink solution that are caused by variations of the pH value can be avoided.
  • As already stated, optimally constant conditions inside the stomach are to be sought for the acquisition of measurement data. This requirement extends not only to the chemical composition of the stomach contents but also to the amount of liquid present in the stomach, for example. In general, a drink solution provided into the stomach remains there only for a relatively short period of time. According to a further exemplary embodiment, the temperature of the drink solution is calibrated essentially to the temperature of the stomach to extend the residence duration. A drink solution that is preheated to approximately body temperature has multiple advantages. On the one hand, temperature-dependent density changes within the drink solution do not occur. Such density changes lead to variations in the index of refraction of the drink solution and thus lead to streak formation in the image data. Moreover, a warm drink solution will drain more slowly from the pylorus into the duodenum than a cold drink solution. The residence duration of the preheated drink solution in the stomach is thus improved.
  • In addition to classical endoscopy and capsule endoscopy, the possibility moreover exists to use a magnetically navigable capsule endoscope to detect measurement values in the stomach of a patient. The aforementioned measures that largely suppress a bubble formation within the stomach of a patient are in particular relevant when such a magnetically controlled endoscopy capsule is used.
  • A technical problem which occurs in the use of a drink solution that has not been degassed is that bubbles accumulate on the outside of the endoscopy capsule. The bubbles—which have accumulated in a partial region, for example—lead there to local buoyancy forces at the capsule endoscope, whereby its control is made significantly more difficult. In the worst case, the capsule can start to tumble; in this case a targeted measurement value acquisition is impossible.
  • The use of a degassed drink solution prevents the situation that bubbles can accumulate at the surface of the capsule endoscope. The capsule endoscope can be navigated without problems. The navigability/mobility of the endoscope capsule inside the stomach can be additionally improved in that a silicone oil is admixed with the drink solution. In addition to the aforementioned effect that the bubble formation is reduced, this has the effect of a lubricant. The friction forces between the capsule endoscope and the drink fluid and between the capsule endoscope and the stomach wall are reduced; the navigability of the capsule is improved.
  • In order to enable a friction-less workflow of the measurements in the stomach of the patient, the drink solution can be provided with the admixtures and be degassed insofar as this is necessary. Such a prepared drink solution must merely be correspondingly tempered before it is brought into the stomach of the patient. Such a prepared drink solution allows a high workflow in the measurement value acquisition.
  • With the use of the described measures it can be achieved that the physical and chemical properties of the drink solution achieve optimally constant conditions in the stomach of the patient during the measurement value acquisition. The measurement value acquisition is more reliable and reproducible.
  • Although modifications and changes may be suggested by those skilled in the art, it is the intention of the inventors to embody within the patent warranted heron all changes and modifications as reasonably and properly come within the scope of their contribution to the art.

Claims (3)

I claim as my invention:
1. A method for acquiring measurement data from the stomach of a patient, comprising the steps of:
degassing an aqueous drink solution by preparing said aqueous drink solution isotonically, and thereafter administering the degassed aqueous drink solution to the stomach of a patient; and
acquiring measurement data from the stomach of the patient using a camera contained in an endoscope with said degassed aqueous drink solution present in the stomach of the patient during the acquisition of the measurement data.
2. A method as claimed in claim 1 comprising preparing said aqueous drink solution isotonically by adding NaCl thereto.
3. A method as claimed in claim 1 comprising acquiring said measurement data by magnetically guiding said capsule endoscope in the stomach of the patient using an extracorporeally-applied magnetic field.
US14/073,170 2008-07-30 2013-11-06 Method for determining measured data from the stomach of a patient Abandoned US20140058199A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/073,170 US20140058199A1 (en) 2008-07-30 2013-11-06 Method for determining measured data from the stomach of a patient
US15/240,340 US10231606B2 (en) 2008-07-30 2016-08-18 Method for determining measured data from the stomach of a patient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102008035542.9 2008-07-30
DE102008035542A DE102008035542A1 (en) 2008-07-30 2008-07-30 Method for determining measurement data from the stomach of a patient
US201113056394A 2011-01-28 2011-01-28
US14/073,170 US20140058199A1 (en) 2008-07-30 2013-11-06 Method for determining measured data from the stomach of a patient

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
PCT/EP2009/054424 Division WO2010012513A2 (en) 2008-07-30 2009-04-15 Method for determining measured data from the stomach of a patient
US13/056,394 Division US20110178368A1 (en) 2008-07-30 2009-04-15 Method for determining measured data from the stomach of a patient
US201113056394A Division 2008-07-30 2011-01-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/240,340 Division US10231606B2 (en) 2008-07-30 2016-08-18 Method for determining measured data from the stomach of a patient

Publications (1)

Publication Number Publication Date
US20140058199A1 true US20140058199A1 (en) 2014-02-27

Family

ID=41461490

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/056,394 Abandoned US20110178368A1 (en) 2008-07-30 2009-04-15 Method for determining measured data from the stomach of a patient
US14/073,170 Abandoned US20140058199A1 (en) 2008-07-30 2013-11-06 Method for determining measured data from the stomach of a patient
US15/240,340 Active 2029-10-10 US10231606B2 (en) 2008-07-30 2016-08-18 Method for determining measured data from the stomach of a patient

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/056,394 Abandoned US20110178368A1 (en) 2008-07-30 2009-04-15 Method for determining measured data from the stomach of a patient

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/240,340 Active 2029-10-10 US10231606B2 (en) 2008-07-30 2016-08-18 Method for determining measured data from the stomach of a patient

Country Status (4)

Country Link
US (3) US20110178368A1 (en)
CN (2) CN102112043A (en)
DE (1) DE102008035542A1 (en)
WO (1) WO2010012513A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389105B2 (en) 2017-10-31 2022-07-19 Brittany Molkenthin Systems and methods for measuring a quantity of breast milk consumed by a baby

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012324004B2 (en) * 2011-11-22 2014-10-02 Suntory Holdings Limited Non-alcohol, beer-taste beverage having high ratio of monosaccharides and disaccharides
AU2012324000B2 (en) * 2011-11-22 2015-11-26 Suntory Holdings Limited Non-alcohol, beer-taste beverage having improved finish
KR20150100643A (en) 2012-12-28 2015-09-02 산토리 홀딩스 가부시키가이샤 Non-alcoholic beer-taste beverage having tangy taste
CN107997791A (en) * 2017-12-15 2018-05-08 赵继国 A kind of cardiovascular devices

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030167000A1 (en) * 2000-02-08 2003-09-04 Tarun Mullick Miniature ingestible capsule
JP2006061213A (en) * 2004-08-24 2006-03-09 Olympus Corp Medical capsule for ultrasonic diagnosis
US20070106112A1 (en) * 2003-12-24 2007-05-10 Daniel Gat Device, system and method for in-vivo imaging of a body lumen
US20070221233A1 (en) * 2005-12-28 2007-09-27 Olympus Medical Systems Corp. Body-insertable device system and in-vivo observation method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3707071C1 (en) * 1987-03-05 1988-08-18 Riwoplan Med Tech Einricht Device for degassing washing water
US4957112A (en) * 1987-11-20 1990-09-18 Olympus Optical Co., Ltd. Ultrasonic diagnostic apparatus
JPH0624531B2 (en) * 1987-11-24 1994-04-06 オリンパス光学工業株式会社 Intracorporeal ultrasound diagnostic device
US5681260A (en) * 1989-09-22 1997-10-28 Olympus Optical Co., Ltd. Guiding apparatus for guiding an insertable body within an inspected object
WO1991018612A1 (en) 1990-06-01 1991-12-12 Unger Evan C Contrast media for ultrasonic imaging
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
DE9305066U1 (en) * 1993-04-02 1993-06-09 Richard Wolf Gmbh, 7134 Knittlingen, De
CN1179284A (en) 1997-11-07 1998-04-22 金松亭 Oral isotonic water
DE10142253C1 (en) 2001-08-29 2003-04-24 Siemens Ag endorobot
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
JP2004041709A (en) 2002-05-16 2004-02-12 Olympus Corp Capsule medical care device
DE10326188A1 (en) * 2003-06-06 2004-11-18 Schering Ag Aqueous silicone oil emulsion for use, e.g. in heat-sterilizable pharmaceuticals, comprises a non-ionic surfactant and shows a change of not more than 20 percent in particle size of the oil phase after heat-sterilization
EP1832267A4 (en) * 2004-12-28 2011-09-14 Olympus Corp Introduction aiding apparatus for encapsulated medical device
US20070225552A1 (en) * 2004-12-28 2007-09-27 Olympus Corporation Introduction-assisting apparatus for capsule medical device
US8372680B2 (en) * 2006-03-10 2013-02-12 Stc.Unm Three-dimensional, ultrasonic transducer arrays, methods of making ultrasonic transducer arrays, and devices including ultrasonic transducer arrays
EP2062522A4 (en) * 2006-09-12 2013-03-27 Olympus Medical Systems Corp Capsule endoscope system, in-vivo information acquisition device, and capsule endoscope

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030167000A1 (en) * 2000-02-08 2003-09-04 Tarun Mullick Miniature ingestible capsule
US20070106112A1 (en) * 2003-12-24 2007-05-10 Daniel Gat Device, system and method for in-vivo imaging of a body lumen
JP2006061213A (en) * 2004-08-24 2006-03-09 Olympus Corp Medical capsule for ultrasonic diagnosis
US20070221233A1 (en) * 2005-12-28 2007-09-27 Olympus Medical Systems Corp. Body-insertable device system and in-vivo observation method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389105B2 (en) 2017-10-31 2022-07-19 Brittany Molkenthin Systems and methods for measuring a quantity of breast milk consumed by a baby

Also Published As

Publication number Publication date
DE102008035542A1 (en) 2010-02-04
WO2010012513A2 (en) 2010-02-04
CN102112043A (en) 2011-06-29
WO2010012513A3 (en) 2010-05-20
US20110178368A1 (en) 2011-07-21
US10231606B2 (en) 2019-03-19
US20160353982A1 (en) 2016-12-08
CN106214113A (en) 2016-12-14

Similar Documents

Publication Publication Date Title
US10231606B2 (en) Method for determining measured data from the stomach of a patient
JP4861463B2 (en) In vivo imaging device
CN102006822B (en) Endocapsule
Metheny et al. Assessing placement of feeding tubes
US7192397B2 (en) Floatable in vivo sensing device and method for use
AU763148B2 (en) Device and method for assessing perfusion failure in a patient during endotracheal intubation
EP3900744B1 (en) Powder for per-oral negative contrast agent
Senagore et al. Intramural pH: a quantitative measurement for predicting colorectal anastomotic healing
US9532705B2 (en) Method for contact-free magnetic navigation
RU2358740C1 (en) Colonoscopy preparation method in children of various age groups
US20220401587A1 (en) Low x-ray attenuation change hard shelled oral contrast material
McKay et al. Medical procedures/testing in pediatric gastroenterology
Cohen Ultrasound of the pediatric upper gastrointestinal tract.
Kuliš et al. The value of scrotal infrared digital thermography in detection of varicocele–initial results
JP3547124B2 (en) Methods and devices for assessing perfusion insufficiency in a patient
Yan et al. Ultrasound and Photoacoustic Guided Gastrostomy to Prevent Colonic Injury
WO2019209897A1 (en) Methods for determining stomach fullness and related methods of medical safety
Hume Diagnostic Evaluation of Gastrointestinal Conditions
Kumar et al. Infantile hypertrophic pyloric stenosis
ADOLPH PHYSIOLOGICAL SOCIETY
Goldsmith Ophthalmology and Otolaryngology.
Spillmann Endoscopy of the gastrointestinal tract when is it really indicated.
SCHRODER The diagnosis of congenital obstruction of the duodenum
RU2244304C1 (en) Method for assay of blood plasma density
Listernick A 30-Month-Old Girl with Persistent Daily Vomiting

Legal Events

Date Code Title Description
AS Assignment

Owner name: SIEMENS AKTIENGESELLSCHAFT, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GLAESEL, NORBERT;KUTH, RAINER;ROAS, BERNHARD;SIGNING DATES FROM 20131210 TO 20131216;REEL/FRAME:032049/0455

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION